Bridge City Capital LLC Reduces Stock Holdings in Pediatrix Medical Group, Inc. $MD

Bridge City Capital LLC decreased its holdings in Pediatrix Medical Group, Inc. (NYSE:MD) by 36.7% in the fourth quarter, HoldingsChannel.com reports. The fund owned 149,948 shares of the company’s stock after selling 86,981 shares during the period. Bridge City Capital LLC’s holdings in Pediatrix Medical Group were worth $3,207,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in MD. Victory Capital Management Inc. lifted its stake in Pediatrix Medical Group by 30.7% in the third quarter. Victory Capital Management Inc. now owns 4,126,207 shares of the company’s stock worth $69,114,000 after acquiring an additional 968,553 shares during the period. American Century Companies Inc. lifted its stake in Pediatrix Medical Group by 38.9% in the third quarter. American Century Companies Inc. now owns 2,682,976 shares of the company’s stock worth $44,940,000 after acquiring an additional 751,109 shares during the period. Allspring Global Investments Holdings LLC purchased a new stake in Pediatrix Medical Group in the fourth quarter worth $13,613,000. Ameriprise Financial Inc. lifted its stake in Pediatrix Medical Group by 175.4% in the second quarter. Ameriprise Financial Inc. now owns 744,473 shares of the company’s stock worth $10,683,000 after acquiring an additional 474,186 shares during the period. Finally, BNP Paribas Financial Markets lifted its stake in Pediatrix Medical Group by 669.4% in the second quarter. BNP Paribas Financial Markets now owns 476,098 shares of the company’s stock worth $6,832,000 after acquiring an additional 414,216 shares during the period. Hedge funds and other institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Stock Performance

Shares of Pediatrix Medical Group stock opened at $24.29 on Friday. The company has a current ratio of 1.33, a quick ratio of 1.33 and a debt-to-equity ratio of 0.45. The firm has a market capitalization of $1.99 billion, a P/E ratio of 11.79 and a beta of 0.69. The business has a fifty day simple moving average of $22.42 and a two-hundred day simple moving average of $21.73. Pediatrix Medical Group, Inc. has a 12 month low of $11.84 and a 12 month high of $24.99.

Pediatrix Medical Group (NYSE:MD) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $0.44 EPS for the quarter, beating the consensus estimate of $0.37 by $0.07. The business had revenue of $476.20 million during the quarter, compared to analyst estimates of $465.83 million. Pediatrix Medical Group had a return on equity of 19.94% and a net margin of 9.02%.The company’s revenue for the quarter was up 3.9% on a year-over-year basis. During the same quarter last year, the firm posted $0.33 earnings per share. On average, equities analysts forecast that Pediatrix Medical Group, Inc. will post 2.1 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages have commented on MD. UBS Group raised their price objective on Pediatrix Medical Group from $22.00 to $25.00 and gave the company a “neutral” rating in a research report on Tuesday, May 12th. Mizuho set a $24.00 price objective on Pediatrix Medical Group in a research report on Friday, May 8th. Jefferies Financial Group reissued a “buy” rating and set a $27.00 price objective on shares of Pediatrix Medical Group in a research report on Monday, April 20th. Weiss Ratings reissued a “hold (c+)” rating on shares of Pediatrix Medical Group in a research report on Friday, March 27th. Finally, Deutsche Bank Aktiengesellschaft set a $19.00 price objective on Pediatrix Medical Group in a research report on Friday, February 20th. One investment analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $22.50.

Insider Activity

In other news, Director Shirley A. Weis sold 36,028 shares of Pediatrix Medical Group stock in a transaction dated Wednesday, May 13th. The stock was sold at an average price of $23.75, for a total value of $855,665.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.80% of the stock is currently owned by corporate insiders.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.